A Study of Raman Spectroscopy as a Clinical Diagnostic Tool for the Detection of Lynch Syndrome/Hereditary NonPolyposis Colorectal Cancer (HNPCC)

Lynch syndrome also known as hereditary non-polyposis colorectal cancer (HNPCC) is a highly penetrant hereditary form of colorectal cancer that accounts for approximately 3% of all cases. It is caused by mutations in DNA mismatch repair resulting in accelerated adenoma to carcinoma progression. The current clinical guidelines used to identify Lynch Syndrome (LS) are known to be too stringent resulting in overall underdiagnoses. Raman spectroscopy is a powerful analytical tool used to probe the molecular vibrations of a sample to provide a unique chemical fingerprint. The potential of using Raman as a diagnostic tool for discriminating LS from sporadic adenocarcinoma is explored within this thesis. A number of experimental parameters were initially optimized for use with formalin fixed paraffin embedded colonic tissue (FFPE). This has resulted in the development of a novel cost-effective backing substrate shown to be superior to the conventionally used calcium fluoride (CaF2). This substrate is a form of silanized super mirror stainless steel that was found to have a much lower Raman background, enhanced Raman signal and complete paraffin removal from FFPE tissues. Performance of the novel substrate was compared against CaF2 by acquiring large high resolution Raman maps from FFPE rat and human colonic tissue. All of the major histological features were discerned from steel mounted tissue with the benefit of clear lipid signals without paraffin obstruction. Biochemical signals were comparable to those obtained on CaF2 with no detectable irregularities. By using principal component analysis to reduce the dimensionality of the dataset it was then possible to use linear discriminant analysis to build a classification model for the discrimination of normal colonic tissue (n=10) from two pathological groups: LS (n=10) and sporadic adenocarcinoma (n=10). Using leaveone-map-out cross-validation of the model classifier has shown that LS was predicted with a sensitivity of 63% and a specificity of 89% - values that are competitive with classification techniques applied routinely in clinical practice

Deep Learning Applied to Raman Spectroscopy for the Detection of Microsatellite Instability/MMR Deficient Colorectal Cancer

Defective DNA mismatch repair is one pathogenic pathway to colorectal cancer. It is characterised by microsatellite instability which provides a molecular biomarker for its detection. Clinical guidelines for universal testing of this biomarker are not met due to resource limitations; thus, there is interest in developing novel methods for its detection. Raman spectroscopy (RS) is an analytical tool able to interrogate the molecular vibrations of a sample to provide a unique biochemical fingerprint. The resulting datasets are complex and high-dimensional, making them an ideal candidate for deep learning, though this may be limited by small sample sizes. This study investigates the potential of using RS to distinguish between normal, microsatellite stable (MSS) and microsatellite unstable (MSI-H) adenocarcinoma in human colorectal samples and whether deep learning provides any benefit to this end over traditional machine learning models. A 1D convolutional neural network (CNN) was developed to discriminate between healthy, MSI-H and MSS in human tissue and compared to a principal component analysis-linear discriminant analysis (PCA-LDA) and a support vector machine (SVM) model. A nested cross-validation strategy was used to train 30 samples, 10 from each group, with a total of 1490 Raman spectra. The CNN achieved a sensitivity and specificity of 83% and 45% compared to PCA-LDA, which achieved a sensitivity and specificity of 82% and 51%, respectively. These are competitive with existing guidelines, despite the low sample size, speaking to the molecular discriminative power of RS combined with deep learning. A number of biochemical antecedents responsible for this discrimination are also explored, with Raman peaks associated with nucleic acids and collagen being implicated

Machine Learning of Raman Spectroscopy Data for Classifying Cancers: A Review of the Recent Literature

Raman Spectroscopy has long been anticipated to augment clinical decision making, such as classifying oncological samples. Unfortunately, the complexity of Raman data has thus far inhibited their routine use in clinical settings. Traditional machine learning models have been used to help exploit this information, but recent advances in deep learning have the potential to improve the field. However, there are a number of potential pitfalls with both traditional and deep learning models. We conduct a literature review to ascertain the recent machine learning methods used to classify cancers using Raman spectral data. We find that while deep learning models are popular, and ostensibly outperform traditional learning models, there are many methodological considerations which may be leading to an over-estimation of performance; primarily, small sample sizes which compound sub-optimal choices regarding sampling and validation strategies. Amongst several recommendations is a call to collate large benchmark Raman datasets, similar to those that have helped transform digital pathology, which researchers can use to develop and refine deep learning models

System transferability of Raman-based oesophageal tissue classification using modern machine learning to support multi-centre clinical diagnostics

Abstract Background The clinical potential of Raman spectroscopy is well established but has yet to become established in routine oncology workflows. One barrier slowing clinical adoption is a lack of evidence demonstrating that data taken on one spectrometer transfers across to data taken on another spectrometer to provide consistent diagnoses. Methods We investigated multi-centre transferability using human oesophageal tissue. Raman spectra were taken across three different centres with different spectrometers of the same make and model. By using a common protocol, we aimed to minimise the difference in machine learning performance between centres. Results 61 oesophageal samples from 51 patients were interrogated by Raman spectroscopy at each centre and classified into one of five pathologies. The overall accuracy and log-loss did not significantly vary when a model trained upon data from any one centre was applied to data taken at the other centres. Computational methods to correct for the data during pre-processing were not needed. Conclusion We have found that when using the same make and model of spectrometer, together with a common protocol, across different centres it is possible to achieve system transferability without the need for additional computational instrument correction

Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure

In a first step toward developing autologous tissue grafts for the treatment of children with intestinal failure, patient-derived jejunal organoids seeded on scaffolds of decellularized human intestinal matrix formed grafts that had jejunal properties and formed luminal structures when transplanted into mice.Intestinal failure, following extensive anatomical or functional loss of small intestine, has debilitating long-term consequences for children(1). The priority of patient care is to increase the length of functional intestine, particularly the jejunum, to promote nutritional independence(2). Here we construct autologous jejunal mucosal grafts using biomaterials from pediatric patients and show that patient-derived organoids can be expanded efficiently in vitro. In parallel, we generate decellularized human intestinal matrix with intact nanotopography, which forms biological scaffolds. Proteomic and Raman spectroscopy analyses reveal highly analogous biochemical profiles of human small intestine and colon scaffolds, indicating that they can be used interchangeably as platforms for intestinal engineering. Indeed, seeding of jejunal organoids onto either type of scaffold reliably reconstructs grafts that exhibit several aspects of physiological jejunal function and that survive to form luminal structures after transplantation into the kidney capsule or subcutaneous pockets of mice for up to 2 weeks. Our findings provide proof-of-concept data for engineering patient-specific jejunal grafts for children with intestinal failure, ultimately aiding in the restoration of nutritional autonomy